Skip to main content
. Author manuscript; available in PMC: 2012 Aug 17.
Published in final edited form as: Brain Disord Ther. 2012;1(1):1000101. doi: 10.4172/bdt.1000101

Figure 1.

Figure 1

Total Neuropsychological Performance in Hematopoietic Cell Transplant Recipients Receiving GMCSF+GCSF versus GCSF only. The GMCSF+GCSF group performed significantly better at 6 months post-HCT (p=.04), but there were no group differences at 12 months post-HCT (p=.24). The GMCSF+GCSF group improved significantly from baseline to 6 months post-HCT (p=.01) and from baseline to 12 months post-HCT (p<.01). The GCSF group demonstrated no change from baseline to 6 months post-HCT (p=.33) but significant improvement from baseline to 12 months post-HCT (p<.01).